Susquehanna Portfolio Strategies’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
VCM
DC
TCM
OCM
IAM
Susquehanna Portfolio Strategies's PGEN Position: Q1 2026 in Review
Susquehanna Portfolio Strategies sold out of Precigen (PGEN) in Q1 2026, closing a stake of 30,482 shares — an estimated $127K sold.
Susquehanna Portfolio Strategies first reported a position in PGEN in Q3 2025 and held it in 2 quarters. The position peaked at $127K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.
- Susquehanna Portfolio Strategies reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
- Susquehanna Portfolio Strategies sold 30,482 Precigen shares in Q1 2026, an estimated $127K.
- Susquehanna Portfolio Strategies first reported a position in Precigen in Q3 2025 and held it in 2 quarters.
- Susquehanna Portfolio Strategies's Precigen position peaked at $127K in Q4 2025.
- 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.